Xilio Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -207.5% | -207.5% | -125.4% |
| FY2024 | -331.0% | -331.0% | -81.9% |
| FY2025 | -99.3% | -99.3% | -22.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -207.5% | -207.5% | -125.4% |
| FY2024 | -331.0% | -331.0% | -81.9% |
| FY2025 | -99.3% | -99.3% | -22.6% |